Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Swine flu outbreak. China first to vaccinate against novel H1N1 virus.

Literature DB >> 19762610

Swine flu outbreak. China first to vaccinate against novel H1N1 virus.

Richard Stone.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2009 PMID： 19762610 DOI： 10.1126/science.325_1482

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.

Authors: Niklas Lindegardh; Warunee Hanpithakpong; Benjamas Kamanikom; Jeremy Farrar; Tran Tinh Hien; Pratap Singhasivanon; Nicholas J White; Nicholas P J Day
Journal: Bioanalysis Date: 2011-01 Impact factor: 2.681

2. Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors: Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal: Viruses Date: 2010-02-01 Impact factor: 5.048

3. Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.

Authors: Shu Meng; Zhonghua Liu; Lili Xu; Li Li; Shan Mei; Linlin Bao; Wei Deng; Lina Li; Rongyue Lei; Liangzhi Xie; Chuan Qin; Linqi Zhang
Journal: PLoS One Date: 2011-05-20 Impact factor: 3.240

4. Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.

Authors: Penghui Yang; Yueqiang Duan; Peirui Zhang; Zhiwei Li; Cheng Wang; Mei Dong; Chong Tang; Li Xing; Hongjing Gu; Zhongpeng Zhao; Xiufan Liu; Shaogeng Zhang; Xiliang Wang
Journal: PLoS One Date: 2012-01-18 Impact factor: 3.240

5. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population.

Authors: Joseph T F Lau; Nelson C Y Yeung; K C Choi; Mabel Y M Cheng; H Y Tsui; Sian Griffiths
Journal: Vaccine Date: 2010-05-08 Impact factor: 3.641

Swine flu outbreak. China first to vaccinate against novel H1N1 virus.

1. Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.

2. Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

3. Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.

4. Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.

5. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population.

6. Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China.

Review 7. Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9.

Review 8. Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics.

9. Economic and health impacts of infectious diseases in China: A protocol for systematic review and meta analysis.